Us Pirfenidone Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Pirfenidone Market was valued at USD 1.25 Billion in 2022 and is projected to reach USD 2.35 Billion by 2030, growing at a CAGR of 8.6% from 2024 to 2030.
The US Pirfenidone Market has seen significant growth in recent years due to the increasing prevalence of idiopathic pulmonary fibrosis (IPF), a chronic lung disease that severely affects breathing and quality of life. Pirfenidone, a pharmaceutical drug, is used to treat this condition by reducing the progression of lung scarring. As the demand for effective treatments rises, the market for Pirfenidone in the US continues to expand, attracting attention from both healthcare professionals and pharmaceutical companies.
In 2024, the US Pirfenidone Market was valued at over $1 billion, with expectations to grow steadily due to the aging population and the increasing diagnosis of IPF. The drug has proven to be a game-changer, offering patients hope by slowing down the disease's progression, making it a cornerstone in managing IPF. Its effectiveness has contributed to its widespread acceptance, but it also faces competition from other emerging treatments in the field.
The market's growth is fueled by several factors, including advancements in medical research, an increase in healthcare awareness, and the ongoing development of new therapies. Pirfenidone has shown positive clinical trial results, strengthening its position in the market. However, high treatment costs and potential side effects can limit patient access, influencing market dynamics.
Additionally, the US Pirfenidone Market is characterized by a robust competitive landscape, with major pharmaceutical companies vying for market share. Companies like Roche and Genentech, which hold significant shares in the market, continue to innovate and push the boundaries of IPF treatment. The demand for Pirfenidone is expected to continue its upward trajectory, making it an essential part of the healthcare industry's focus on respiratory diseases.
The rising adoption of innovative therapies, along with increasing healthcare investments, creates opportunities for both established and new players in the Pirfenidone market. With the growing focus on diseases like IPF, which impacts millions in the US, the US Pirfenidone Market is poised for sustained growth. Market trends also indicate that a shift towards personalized treatments will further define the future landscape of Pirfenidone use.
As with many healthcare markets, the future of Pirfenidone remains dynamic. Companies will need to balance price, accessibility, and treatment efficacy to maintain patient loyalty and expand their market share. The outlook remains optimistic as research into pulmonary diseases advances, ensuring that the US Pirfenidone Market continues to evolve in a patient-centered direction.
Get an In-Depth Research Analysis of the Global Pirfenidone Market Size And Forecast [2025-2032]
Â
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Pirfenidone Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Pirfenidone Market
Idiopathic Pulmonary Fibrosis (IPF)
Non-Small Cell Lung Cancer (NSCLC)
Systemic Sclerosis-Induced Fibrosis
Oral Tablets
Injectable Formulations
Intravenous Administration
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Direct Sales
Hospitals
Specialty Clinics
Homecare Settings
Research Institutions
Immediate Release
Extended Release
Combination Therapies
Generic Versions
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Pirfenidone Market Research Analysis
1. Introduction of the Global Pirfenidone Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Pirfenidone Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Pirfenidone Market, By Type
6. Global Pirfenidone Market, By Application
7. Global Pirfenidone Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Pirfenidone Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/